CRI integrates the whole industry chain from early scientific research, commercial transformation, clinical research to market promotion by actively introducing domestic high-quality biomedical service providers, thus promoting research and development and application of biomedical products, lowering barriers between clinical demand and basic research, and finally committing itself to building the most active biomedical and pharmaceutical ecosystem in China.